Dentsply Sirona (XRAY) Tops Q4 EPS by 14c; Guides FY23

Dentsply Sirona (NASDAQ: XRAY) reported Q4 EPS of $0.46, $0.14 better than the analyst estimate of $0.32. Revenue for the quarter came in at $983 million versus the consensus estimate of $941.33 million.

GUIDANCE:

Dentsply Sirona sees Q1 2023 EPS of $1.80-$2.00, versus the consensus of $1.84. Dentsply Sirona sees Q1 2023 revenue of $3.85-3.95 billion, versus the consensus of $3.82 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
• United Natural Foods (UNFI) Reports In-Line Q3 EPS ; Offers Outlook